Pharma & Biotech

Centene Corporation’s stock continues to face headwinds as a critical September 8 deadline approaches for investors seeking lead plaintiff status...

Pharmaceutical giant Eli Lilly finds itself navigating a complex pricing landscape as new regulatory measures from the Trump administration compel...

While numerous healthcare sector stocks continue grappling with pandemic aftershocks and broader economic headwinds, medical technology giant Becton Dickinson is...

The coming weeks represent a pivotal period for clinical-stage biotech company AnaptysBio, whose immunology-focused pipeline faces a significant test. With...

The biopharmaceutical company Liquidia Corporation has captured significant analyst attention following the remarkably successful commercial launch of its flagship pulmonary...

NuCana plc faces persistent selling pressure following a substantial reverse stock split, with the oncology-focused company releasing a new investor...

A significant regulatory milestone achieved by Mainz-based biotechnology firm BioNTech in late August has reignited investor optimism. The U.S. Food...

While reporting improved quarterly figures, biotechnology firm Rallybio finds itself in a precarious battle for its stock market survival. The...

Immunocore Holdings is demonstrating why it remains a compelling story within the biotech sector. The company's recent quarterly performance, underpinned...

Neurocrine Biosciences shares are demonstrating remarkable resilience in a biotech sector often characterized by extreme volatility. The neuropharmaceutical company has...